Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study

BMJ. 1998 Apr 11;316(7138):1132-3. doi: 10.1136/bmj.316.7138.1132.

Authors

P Maison¹, B Balkau, D Simon, P Chanson, G Rosselin, E Eschwège

Affiliation

¹ Institut National de la Santé et de la Recherche Médicale Unité 21, Faculté de Médecine Paris Sud, Villejuif, France.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cardiovascular Diseases / mortality*
Cause of Death
Diabetes Mellitus / mortality*
Follow-Up Studies
Glucose Intolerance / mortality*
Growth Hormone / adverse effects*
Humans
Male
Middle Aged
Neoplasms / mortality*
Paris / epidemiology
Proportional Hazards Models
Prospective Studies

Substances

Growth Hormone